StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Pharmacy & Consumer Wellness Revenue by Source

Pharmacy & Consumer Wellness Revenue by Source — Products ($M)

QuarterlyAnnual

Cvs Health Pharmacy & Consumer Wellness Revenue by Source: $136,575M in FY2025, up 11.9% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
136,575
Period ended Dec 31, 2025
Change on a year earlier
+11.9%
122,028 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Products | $ | 136,575 | $ | 122,028 | $ | 113,976 | $ | 14,547 | 11.9 | % | $ | 8,052 | 7.1 | %”

Source: CVS Health 10-K (2026-02-10) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPharmacy & Consumer Wellness Revenue by Source — Products ($M)Year on yearSource
FY2025Dec 31, 2025136,575+11.9%CVS Health 10-K (2026-02-10) ↗
FY2024Dec 31, 2024122,028+7.1%CVS Health 10-K (2026-02-10) ↗
FY2023Dec 31, 2023113,976+8.7%CVS Health 10-K (2026-02-10) ↗
FY2022Dec 31, 2022104,878+8.3%CVS Health 10-K (2025-02-12) ↗
FY2021Dec 31, 202196,852+7.7%CVS Health 10-K (2024-02-07) ↗
FY2020Dec 31, 202089,944+4.9%CVS Health 10-K (2023-02-08) ↗
FY2019Dec 31, 201985,729+3.1%CVS Health 10-K (2022-02-09) ↗
FY2018Dec 31, 201883,175+5.9%CVS Health 10-K (2021-02-16) ↗
FY2017Dec 31, 201778,522–CVS Health 10-K (2020-02-18) ↗

Cite this data

StockData. (2026). Cvs Health Pharmacy & Consumer Wellness Revenue by Source ($M), annual FY2017–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw-rev-products

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.